search icon
kymr-img

Kymera Therapeutics Inc, Common Stock

KYMR

NMQ

$30.25

+$1.45

(5.03%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$1.96B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
936.06K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.19
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$19.45 L
$53.27 H
$30.25

About Kymera Therapeutics Inc, Common Stock

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameKYMRSectorS&P500
1-Week Return0.27%0.71%0.79%
1-Month Return-10.21%-5.6%6.04%
3-Month Return-3.51%-11.72%-1.11%
6-Month Return-35.43%-10.81%-2.39%
1-Year Return-6.89%-7.12%11.69%
3-Year Return111.98%-0.57%42.29%
5-Year Return-9.05%27.64%93.12%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue34.03M72.83M46.83M78.59M47.07M[{"date":"2020-12-31","value":43.3,"profit":true},{"date":"2021-12-31","value":92.67,"profit":true},{"date":"2022-12-31","value":59.58,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":59.89,"profit":true}]
Cost of Revenue62.10M2.40M2.98M189.08M7.37M[{"date":"2020-12-31","value":32.85,"profit":true},{"date":"2021-12-31","value":1.27,"profit":true},{"date":"2022-12-31","value":1.57,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":3.9,"profit":true}]
Gross Profit(28.07M)70.44M43.85M(110.49M)39.70M[{"date":"2020-12-31","value":-39.85,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":62.25,"profit":true},{"date":"2023-12-31","value":-156.87,"profit":false},{"date":"2024-12-31","value":56.36,"profit":true}]
Gross Margin(82.48%)96.71%93.64%(140.59%)84.34%[{"date":"2020-12-31","value":-85.29,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.83,"profit":true},{"date":"2023-12-31","value":-145.37,"profit":false},{"date":"2024-12-31","value":87.21,"profit":true}]
Operating Expenses80.34M173.36M208.08M244.12M308.71M[{"date":"2020-12-31","value":26.02,"profit":true},{"date":"2021-12-31","value":56.16,"profit":true},{"date":"2022-12-31","value":67.4,"profit":true},{"date":"2023-12-31","value":79.08,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(46.30M)(100.53M)(161.26M)(165.53M)(261.63M)[{"date":"2020-12-31","value":-4630400000,"profit":false},{"date":"2021-12-31","value":-10053000000,"profit":false},{"date":"2022-12-31","value":-16125600000,"profit":false},{"date":"2023-12-31","value":-16553000000,"profit":false},{"date":"2024-12-31","value":-26163500000,"profit":false}]
Total Non-Operating Income/Expense1.42M626.00K12.90M37.14M75.55M[{"date":"2020-12-31","value":1.88,"profit":true},{"date":"2021-12-31","value":0.83,"profit":true},{"date":"2022-12-31","value":17.07,"profit":true},{"date":"2023-12-31","value":49.15,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(45.59M)(100.22M)(154.81M)(146.96M)(223.86M)[{"date":"2020-12-31","value":-4559300000,"profit":false},{"date":"2021-12-31","value":-10021700000,"profit":false},{"date":"2022-12-31","value":-15480800000,"profit":false},{"date":"2023-12-31","value":-14696200000,"profit":false},{"date":"2024-12-31","value":-22385800000,"profit":false}]
Income Taxes(1.65M)(2.22M)(2.98M)18.76M-[{"date":"2020-12-31","value":-8.78,"profit":false},{"date":"2021-12-31","value":-11.84,"profit":false},{"date":"2022-12-31","value":-15.87,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(43.95M)(98.00M)(151.83M)(165.73M)-[{"date":"2020-12-31","value":-4394500000,"profit":false},{"date":"2021-12-31","value":-9799500000,"profit":false},{"date":"2022-12-31","value":-15183100000,"profit":false},{"date":"2023-12-31","value":-16572600000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(45.59M)(100.22M)(154.81M)(146.96M)(223.86M)[{"date":"2020-12-31","value":-4559300000,"profit":false},{"date":"2021-12-31","value":-10021700000,"profit":false},{"date":"2022-12-31","value":-15480800000,"profit":false},{"date":"2023-12-31","value":-14696200000,"profit":false},{"date":"2024-12-31","value":-22385800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(43.95M)(98.00M)(151.83M)(146.96M)(223.86M)[{"date":"2020-12-31","value":-4394500000,"profit":false},{"date":"2021-12-31","value":-9799500000,"profit":false},{"date":"2022-12-31","value":-15183100000,"profit":false},{"date":"2023-12-31","value":-14696200000,"profit":false},{"date":"2024-12-31","value":-22385800000,"profit":false}]
EPS (Diluted)(2.06)(2.06)(2.88)(2.52)(2.91)[{"date":"2020-12-31","value":-206,"profit":false},{"date":"2021-12-31","value":-206,"profit":false},{"date":"2022-12-31","value":-288,"profit":false},{"date":"2023-12-31","value":-252,"profit":false},{"date":"2024-12-31","value":-291,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

KYMR
Cash Ratio 7.85
Current Ratio 8.49

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

KYMR
ROA (LTM) -19.47%
ROE (LTM) -32.17%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

KYMR
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.86

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

KYMR
Trailing PE NM
Forward PE NM
P/S (TTM) 33.45
P/B 2.51
Price/FCF NM
EV/R 27.05
EV/Ebitda NM

FAQs

What is Kymera Therapeutics Inc share price today?

Kymera Therapeutics Inc (KYMR) share price today is $30.25

Can Indians buy Kymera Therapeutics Inc shares?

Yes, Indians can buy shares of Kymera Therapeutics Inc (KYMR) on Vested. To buy Kymera Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KYMR stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Kymera Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Kymera Therapeutics Inc (KYMR) via the Vested app. You can start investing in Kymera Therapeutics Inc (KYMR) with a minimum investment of $1.

How to invest in Kymera Therapeutics Inc shares from India?

You can invest in shares of Kymera Therapeutics Inc (KYMR) via Vested in three simple steps:

  • Click on Sign Up or Invest in KYMR stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Kymera Therapeutics Inc shares
What is Kymera Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Kymera Therapeutics Inc (KYMR) is $53.27. The 52-week low price of Kymera Therapeutics Inc (KYMR) is $19.45.

What is Kymera Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Kymera Therapeutics Inc (KYMR) is 2.51

What is the Market Cap of Kymera Therapeutics Inc?

The market capitalization of Kymera Therapeutics Inc (KYMR) is $1.96B

What is Kymera Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Kymera Therapeutics Inc is KYMR

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top